Benzethonium Chloride Plus Dyclonine Hydrochloride Liquid
NDC Package 68016-615-00

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Benzethonium Chloride Plus Dyclonine Hydrochloride (liquid bandage) liquids is clean affected areaapply a small amount on the area 1-3 times dailylet drya second coating may be applied for extra protectionto remove, apply more Liquid Bandage and quickly wipe offfinger nil polish remover may dissolve Liquid Bandage. This formulation utilizes a liquid delivery system. Marketed by Chain Drug Consortium, Llc, this product is identified by NDC 68016-615 and is authorized under FDA application M003.

Identification & Billing

NDC Package Code
68016-615-00
Package Description
9 mL in 1 BOTTLE, WITH APPLICATOR
Product Code
68016-615
11-Digit Billing Format
68016061500

Clinical Specifications

Proprietary Name
Benzethonium Chloride Plus Dyclonine Hydrochloride
Non-Proprietary Name
Liquid Bandage
Substance Name
Benzethonium Chloride; Dyclonine Hydrochloride
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
Clean affected areaapply a small amount on the area 1-3 times dailylet drya second coating may be applied for extra protectionto remove, apply more Liquid Bandage and quickly wipe offfinger nil polish remover may dissolve Liquid Bandage

Regulatory & Marketing

Labeler Name
Chain Drug Consortium, Llc
Product Type
Human Otc Drug
FDA Application #
M003
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
12-07-2005
End Marketing Date
04-30-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68016-615-00 identifies a specific commercial package of 9 ml in 1 bottle, with applicator of Benzethonium Chloride Plus Dyclonine Hydrochloride, a human over the counter drug labeled by Chain Drug Consortium, Llc. This liquid is formulated for topical use and contains benzethonium chloride; dyclonine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Chain Drug Consortium, Llc on December 07, 2005.

How is this Chain Drug Consortium, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68016061500. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
68016-615-00
11-Digit CMS (5-4-2)
68016-0615-00

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.